Related AEs (N = 23)
| CTCAE preferred term . | Frequency, N (%) E . | ||
|---|---|---|---|
| Mild . | Moderate . | Severe . | |
| Asthenia | 1 (4%) 1 | ||
| Fever | 2 (8%) 2 | 1 (4%) 1 | |
| Chill | 1 (4%) 1 | ||
| Vertigo | 1 (4%) 1 | ||
| Rash | 3 (13%) 3 | 1 (4%) 1 | |
| Pruritus | 4 (17%) 4 | 1 (4%) 1 | |
| Erythema | 1 (5%) 1 | - | |
| Sinus bradycardia | 1 (4%) 1 | 1 (4%) 1 | |
| Diarrhea | 1 (4%) 2 | ||
| Lipase increased | 1 (4%) 1 | ||
| Headache | 1 (4%) 1 | ||
| Dizziness/malaise | 1 (4%) 1 | ||
| Gynecomastia | 1 (4%) 1 | ||
| CTCAE preferred term . | Frequency, N (%) E . | ||
|---|---|---|---|
| Mild . | Moderate . | Severe . | |
| Asthenia | 1 (4%) 1 | ||
| Fever | 2 (8%) 2 | 1 (4%) 1 | |
| Chill | 1 (4%) 1 | ||
| Vertigo | 1 (4%) 1 | ||
| Rash | 3 (13%) 3 | 1 (4%) 1 | |
| Pruritus | 4 (17%) 4 | 1 (4%) 1 | |
| Erythema | 1 (5%) 1 | - | |
| Sinus bradycardia | 1 (4%) 1 | 1 (4%) 1 | |
| Diarrhea | 1 (4%) 2 | ||
| Lipase increased | 1 (4%) 1 | ||
| Headache | 1 (4%) 1 | ||
| Dizziness/malaise | 1 (4%) 1 | ||
| Gynecomastia | 1 (4%) 1 | ||
CTCAE indicates Common Terminology Criteria for Adverse Events.